Synergistic interaction of the Neu proto-oncogene product and transforming growth factor α in the mammary epithelium of transgenic mice

Molecular and Cellular Biology

Volumn 16, Issue 10, 1996, Pages 5726-5736

  Muller, William J ^a   Arteaga, Carlos L ^b   Muthuswamy, Senthil K ^a   Siegel, Peter M ^a   Webster, Marc A ^a   Cardiff, Robert D ^c   Meise, Katherine S ^b   Li, Feng ^b   Halter, Susan A ^b   Coffey, Robert J ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b VANDERBILT UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ONCOPROTEIN; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; BREAST EPITHELIUM; BREAST TUMOR; CARCINOGENESIS; CONTROLLED STUDY; HISTOPATHOLOGY; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSACTIVATION;

ANIMALIA; MAMMARY TUMOR ONCOVIRUS; MAMMARY TUMOR VIRUS; MOUSE MAMMARY TUMOR VIRUS; MUS MUSCULUS; ONCOVIRINAE; TUMOR VIRUS;

EID: 10144255098     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.16.10.5726     Document Type: Article

References (39)

1. Akiyama, T., T. Saito, H. Ogawara, K. Toyoshima, and T. Yamamoto. 1988. Tumor promoter and epidermal growth factor stimulate phosphorylation of the c-erbB-2 gene product in MKN-7 human adenocarcinoma cells. Mol. Cell. Biol. 8:1019-1026.
2. Arteaga, C. L., M. D. Johnson, G. Todderud, R. J. Coffey, G. Carpenter, and D. L. Page. 1991. Elevated content of the tyrosine kinase substrate phospholipase C-γ1 in primary human breast carcinomas. Proc. Natl. Acad. Sci. USA 88:10435-10439.
3. Bargmann, C. I., M.-C. Hung, and R. A. Weinberg. 1986. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 45:649-657.
4. Bouchard, L., L. Lamarre, P. J. Tremblay, and P. Jolicoeur. 1989. Stochastic appearance of mammary tumors in transgenic mice carrying the activated c-neu oncogene. Cell 57:931-936.
5. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
6. Drebin, J. A., D. F. Stern, V. C. Link, R. A. Weinberg, and M. I. Greene. 1984. Monoclonal antibodies identity a cell-surface antigen associated with an activated cellular oncogene. Nature (London) 312:543-548.
7. Fowler, K. J., F. Walker, W. Alexander, M. L. Hibbs, E. C. Nice, R. M. Bohmer, G. B. Mann, C. Thumwood, R. Maglitto, J. Danks, R. Chetty, A. W. Burgess, and A. R. Dunn. 1995. A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation. Proc. Natl. Acad. Sci. USA 92:1465-1469.
8. Goldman, R., R. Ben-Levy, E. Peles, and Y. Yarden. 1990. Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation. Biochemistry 29:11024-11028.
9. Gullick, W. J., S. B. Love, C. Wright, D. M. Barnes, B. Gutterson, A. L. Harris, and D. G. Altman. 1991. c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. Br. J. Cancer 63:434-438.
10. Guy, C. T., M. A. Webster, M. Schaller, T. J. Parson, R. D. Cardiff, and W. J. Muller. 1992. Expression of the neu proto-oncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. USA 89:10578-10582.
11. Jhappan, C., C. Stahle, R. Harkins, N. Fausto, G. Smith, and G. Merlino. 1990. TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 61:1137-1146.
12. King, C. R., M. H. Kraus, and S. A. Aaronson. 1985. Amplification of a novel v-erbB related gene in human mammary carcinoma. Science 229:974-976.
13. Kokai, Y., K. Dobashi, D. B. Weiner, J. N. Myers, P. C. Nowell, and M. I. Greene. 1988. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products. Proc. Natl. Acad. Sci. USA 85:5389-5393.
14. Kokai, Y., J. N. Meyers, T. Wada, V. I. Brown, C. M. LeVea, J. G. Davis, K. Dobashi, and M. I. Greene. 1989. Synergistic interaction of p185 neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell 58:287-292.
15. Kraus, M. H., I. Issing, T. Miki, N. C. Popescu, and S. A. Aaronson. 1989. Isolation and characterization of ERBB-3, a third member of the ERBB, epidermal growth factor receptor family. Evidence for overexpression in a subset of human mammary tumors. Proc. Natl. Acad. Sci. USA 86:9193-9197.
16. Lacroix, H., J. D. Iglehart, M. A. Skinner, and M. Kraus. 1988. Overexpression of erbB-2 or EGF receptor proteins in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases. Oncogene 3:145-152.
17. Lutteke, N. C., H. K. Phillips, T. H. Qiu, N. G. Copeland, H. S. Earp, N. A. Jenkins, and D. C. Lee. 1994. The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev. 8:399-413.
18. Matsui, Y., S. Halter, J. Holt, B. Hogan, and R. Coffey. 1990. Development of mammary hyperplasia and neoplasia in MMTV-TGFα transgenic mice. Cell 61:1147-1155.
19. Melton, D. A., P. A. Krieg, M. R. Rebagliati, T. Maniatis, K. Zinn, and M. R. Green. 1984. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 12:7035-7056.
20. Mori, N., J. Singer-Sam, C.-Y. Lee, and A. D. Riggs. 1986. The nucleotide sequence of a cDN A clone containing the entire coding region for the mouse X-chrormisome-linked phosphoglycerate kinase. Gene 45:275-280.
21. Muller, W. J., E. Sinn, R. Wallace, P. K. Pattengale, and P. Leder. 1988. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54:105-115.
22. Muthuswamy, S. K., and W. J. Muller. 1994. Unpublished observations.
23. Muthuswamy, S. K., and W. J. Muller. 1995. Direct and specific interaction of c-Src with Neu is involved in signaling by the epidermal growth factor receptor. Oncogene 11:271-279.
24. Muthuswamy, S. K., P. M. Siegel, D. L. Dankort, M. A. Webster, and W. J. Muller. 1994. Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity. Mol. Cell. Biol. 14:735-743.
25. Paterson, M. C., K. D. Dietrich, J. Danyluk, A. H. Paterson, A. W. Lees, N. Jamil, J. Hanson, H. Jenkins, B. E. Krause, W. A. McBlain, D. J. Slamon, and R. M. Fourney. 1991. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer. Cancer Res. 51: 556-567.
26. Plowman, G., J. M. Colouscou, G. Whitney, J. Green, G. Carlton, L. Foy, M. Neubauer, and M. Shoyab. 1993. Ligand-specific activation of HER4/p180/ erbB-4, a fourth member of the epidermal growth factor receptor family. Proc. Natl. Acad. Sci. USA 90:1746-1750.
27. Plowman, G., G. Whitney, M. Neubaue, J. Green, V. McDonald, G. Todaro, and M. Shoyab. 1990. Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc. Natl. Acad. Sci. USA 87:4905-4909.
28. Pringent, S. A., and W. J. Gullick. 1994. Identification of c-erbB-3 binding sites for phosphatidylinositol 3′-kinase and SHC using an EGF receptor/c-erbB-3 chimera. EMBO J. 13:2831-2841.
29. Sandgren, E., N. C. Lutteke, R. D. Palmiter, R. Brinster, and D. Lee. 1990. Overexpression of TGFα in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 61:1121-1135.
30. Shawver, L. K., E. Mann, S. S. Elliger, T. C. Dugger, and C. L. Arteaga. 1994. Ligand-like effects induced by anti-c-erbB-2 antibodies do not correlate and are required for growth inhibition of human carcinoma cells. Cancer Res. 54:1367-1373.
31. Siegel, P. M., D. L. Dankort, W. R. Hardy, and W. J. Muller. 1994. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol. Cell. Biol. 14:7068-7077.
32. Slamon, D. J., G. M. Clark, S. G. Wong, W. J. Levin, A. Ullrich, and W. L. McGuire. 1987. Human breast cancer: correlation of relapse and survival with amplification of Her-2/neu oncogene. Science 235:177-182.
33. Slamon, D. J., W. Godolphin, L. A. Jones, J. A. Holt, S. G. Wong, D. E. Keith, W. J. Levin, S. G. Styart, J. Udove, A. Ullrich, and M. F. Press. 1989. Studies of the HER-2/neu protooncogene in human breast and ovarian cancer. Science 244:707-712.
34. Soltofff, S. P., K. L. Carraway III, S. A. Prigent, W. G. Gullick, and L. C. Cantley. 1994. ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Mol. Cell. Biol. 14:3550-3558.
35. Stern, D. F., and M. P. Kamps. 1988. EGF-stimulated tyrosine phosphorylation of p185 neu: a potential model for receptor interactions. EMBO J. 7:995-1001.
36. Ullrich, A., and J. Schlessinger. 1990. Signal transduction by receptors of tyrosine kinase activity. Cell 61:203-212.
37. van de Vijver, M., R. van de Bersselaar, P. Devilee, C. Cornelisse, J. Peterse, and R. Nusse. 1987. Amplification of the neu (c-erbB-2) oncogene in human mammary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene. Mol. Cell. Biol. 7:2019-2023.
38. Wada, T., J. Myers, Y. Kokai, V. Brown, J. Hamuro, C. LaVea, and M. I. Greene. 1990. Anti-receptor antibodies reverse the phenotype of cells transformed by two interacting proto-oncogene encoded proteins. Oncogene 5:489-495.
39. Wada, T., X. Quain, and M. I. Greene. 1990. Intermolecular association of p185 neu proteins and the EGF receptor modulates EGF receptor function. Cell 61:1339-1347.